UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 139

Sortiert nach

Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines

British journal of cancer, 2011-07, Vol.105 (3), p.372-381

2011

Volltextzugriff (PDF)

Intake of coffee, caffeine and other methylxanthines and risk of Type I vs Type II endometrial cancer

British journal of cancer, 2013-10, Vol.109 (7), p.1908-1913

2013

Volltextzugriff (PDF)

A role for ATR in the DNA damage-induced phosphorylation of p53

Genes & development, 1999-01, Vol.13 (2), p.152-157

1999

Volltextzugriff (PDF)

Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints

The EMBO journal, 1998-01, Vol.17 (1), p.159-169

1998

Volltextzugriff (PDF)

Vaginal vs. robotic hysterectomy for patients with endometrial cancer: A comparison of outcomes and cost of care

Gynecologic oncology, 2017-06, Vol.145 (3), p.555-561

2017

Volltextzugriff (PDF)

Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies

Gynecologic oncology, 2019-01, Vol.152 (1), p.151-156

2019

Volltextzugriff (PDF)

A prospective algorithm to reduce anastomotic leaks after rectosigmoid resection for gynecologic malignancies

Gynecologic oncology, 2017-02, Vol.144 (2), p.343-347

2017

Volltextzugriff (PDF)

Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: A delicate balance requiring individualization

Gynecologic oncology, 2011-11, Vol.123 (2), p.187-191

2011

Volltextzugriff (PDF)

Patients triaged to neoadjuvant chemotherapy have higher rates of sarcopenia: An opportunity for prehabilitation

Gynecologic oncology, 2021-01, Vol.160 (1), p.40-44

2021

Volltextzugriff (PDF)

Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer

Gynecologic oncology, 2013-10, Vol.131 (1), p.103-108

2013

Volltextzugriff (PDF)

Evidence-based wound classification for vulvar surgery: Implications for risk adjustment

Gynecologic oncology, 2019-08, Vol.154 (2), p.280-282

2019

Volltextzugriff (PDF)

From randomized trial to practice: single institution experience using the GOG 172 i.p. chemotherapy regimen for ovarian cancer

Annals of oncology, 2010-09, Vol.21 (9), p.1772-1778

2010

Volltextzugriff (PDF)

Risk factors that mitigate the role of paraaortic lymphadenectomy in uterine endometrioid cancer

Gynecologic oncology, 2013-09, Vol.130 (3), p.441-445

2013

Volltextzugriff (PDF)

Management of endometrial cancer: issues and controversies

European journal of gynaecological oncology, 2016, Vol.37 (1), p.6-12

2016

Volltextzugriff (PDF)

Somatic Mutations in the STK11/LKB1 Gene Are Uncommon in Rare Gynecological Tumor Types Associated with Peutz-Jegher's Syndrome

The American journal of pathology, 2000, Vol.156 (1), p.339-345

2000

Volltextzugriff (PDF)

Disparities in Ovarian Cancer Care Quality and Survival According to Race and Socioeconomic Status

JNCI : Journal of the National Cancer Institute, 2013-06, Vol.105 (11), p.823-832

2013

Volltextzugriff (PDF)

Exploring global barriers to optimal ovarian cancer care: thematic analysis

International journal of gynecological cancer, 2024-05, p.ijgc-2024-005449

2024

Volltextzugriff (PDF)

Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas

Cancer research (Chicago, Ill.), 1993-10, Vol.53 (19), p.4456-4460

1993

Volltextzugriff (PDF)

Cervical Cancer Complicated by Pregnancy: Episiotomy Site Recurrences Following Vaginal Delivery

Obstetrics and gynecology (New York. 1953), 1994-08, Vol.84 (2), p.179-182

1994

Volltextzugriff (PDF)

Skene's Gland Adenocarcinoma with Increased Serum Level of Prostate-Specific Antigen

Gynecologic oncology, 1994-11, Vol.55 (2), p.304-307

1994

Volltextzugriff (PDF)

Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus

Cancer research (Chicago, Ill.), 1994-02, Vol.54 (3), p.610-613

1994

Volltextzugriff (PDF)

Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas

The American journal of pathology, 1993-03, Vol.142 (3), p.733-741

1993

Volltextzugriff (PDF)

Female Urethral Adenocarcinoma: Evidence for More Than One Tissue of Origin?

Gynecologic oncology, 1995-12, Vol.59 (3), p.352-357

1995

Volltextzugriff (PDF)

Second-Look Surgery in the Management of Epithelial Ovarian Carcinoma

Gynecologic oncology, 1994-12, Vol.55 (3), p.S128-S133

1994

Volltextzugriff (PDF)

Unusual Recurrence of Ovarian Carcinoma 9 Years after Initial Diagnosis

Gynecologic oncology, 1999-09, Vol.74 (3), p.495-498

1999

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(137)
Mit Volltextzugriff
(132)

Publikationsform

Artikel
(137)
Tagungsberichte
(2)

Sprache

Englisch
(139)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(82)
Life Sciences & Biomedicine
(81)
Humans
(77)
Female
(74)
Oncology
(58)
Obstetrics & Gynecology
(48)
Obstetrics And Gynecology
(44)
Hematology, Oncology And Palliative Medicine
(42)
Biological And Medical Sciences
(40)
Medical Sciences
(39)
Middle Aged
(39)
Aged
(34)
Tumors
(34)
Gynecology. Andrology. Obstetrics
(32)
Female Genital Diseases
(31)
Ovarian Neoplasms - Pathology
(30)
Adult
(28)
Neoplasm Staging
(23)
Ovarian Cancer
(23)
Aged, 80 And Over
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines

Intake of coffee, caffeine and other methylxanthines and risk of Type I vs Type II endometrial cancer

A role for ATR in the DNA damage-induced phosphorylation of p53

Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints

Vaginal vs. robotic hysterectomy for patients with endometrial cancer: A comparison of outcomes and cost of care

Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies

A prospective algorithm to reduce anastomotic leaks after rectosigmoid resection for gynecologic malignancies

Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: A delicate balance requiring individualization

Patients triaged to neoadjuvant chemotherapy have higher rates of sarcopenia: An opportunity for prehabilitation

Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer

Evidence-based wound classification for vulvar surgery: Implications for risk adjustment

From randomized trial to practice: single institution experience using the GOG 172 i.p. chemotherapy regimen for ovarian cancer

Risk factors that mitigate the role of paraaortic lymphadenectomy in uterine endometrioid cancer

Management of endometrial cancer: issues and controversies

Somatic Mutations in the STK11/LKB1 Gene Are Uncommon in Rare Gynecological Tumor Types Associated with Peutz-Jegher's Syndrome

Disparities in Ovarian Cancer Care Quality and Survival According to Race and Socioeconomic Status

Exploring global barriers to optimal ovarian cancer care: thematic analysis

Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas

Cervical Cancer Complicated by Pregnancy: Episiotomy Site Recurrences Following Vaginal Delivery

Skene's Gland Adenocarcinoma with Increased Serum Level of Prostate-Specific Antigen

Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus

Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas

Female Urethral Adenocarcinoma: Evidence for More Than One Tissue of Origin?

Second-Look Surgery in the Management of Epithelial Ovarian Carcinoma

Unusual Recurrence of Ovarian Carcinoma 9 Years after Initial Diagnosis

Suchergebnisse filtern